260 related articles for article (PubMed ID: 20219906)
21. Identification of the first synthetic inhibitors of the type II transmembrane serine protease TMPRSS2 suitable for inhibition of influenza virus activation.
Meyer D; Sielaff F; Hammami M; Böttcher-Friebertshäuser E; Garten W; Steinmetzer T
Biochem J; 2013 Jun; 452(2):331-43. PubMed ID: 23527573
[TBL] [Abstract][Full Text] [Related]
22. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus.
Horimoto T; Kawaoka Y
J Virol; 1994 May; 68(5):3120-8. PubMed ID: 8151777
[TBL] [Abstract][Full Text] [Related]
23. Pathogenic potential of North American H7N2 avian influenza virus: a mutagenesis study using reverse genetics.
Lee CW; Lee YJ; Senne DA; Suarez DL
Virology; 2006 Sep; 353(2):388-95. PubMed ID: 16828833
[TBL] [Abstract][Full Text] [Related]
24. Genetic analysis of avian influenza A viruses isolated from domestic waterfowl in live-bird markets of Hanoi, Vietnam, preceding fatal H5N1 human infections in 2004.
Jadhao SJ; Nguyen DC; Uyeki TM; Shaw M; Maines T; Rowe T; Smith C; Huynh LP; Nghiem HK; Nguyen DH; Nguyen HK; Nguyen HH; Hoang LT; Nguyen T; Phuong LS; Klimov A; Tumpey TM; Cox NJ; Donis RO; Matsuoka Y; Katz JM
Arch Virol; 2009; 154(8):1249-61. PubMed ID: 19578928
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Glu11 and Gly8 of the H5N1 influenza hemagglutinin fusion peptide in membrane fusion using pseudotype virus and reverse genetics.
Su Y; Zhu X; Wang Y; Wu M; Tien P
Arch Virol; 2008; 153(2):247-57. PubMed ID: 18030546
[TBL] [Abstract][Full Text] [Related]
26. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
Hashimoto T; Kato M; Shimomura T; Kitamura N
FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
[TBL] [Abstract][Full Text] [Related]
27. TMPRSS2 and MSPL Facilitate Trypsin-Independent Porcine Epidemic Diarrhea Virus Replication in Vero Cells.
Shi W; Fan W; Bai J; Tang Y; Wang L; Jiang Y; Tang L; Liu M; Cui W; Xu Y; Li Y
Viruses; 2017 May; 9(5):. PubMed ID: 28524070
[TBL] [Abstract][Full Text] [Related]
28. Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections.
Böttcher-Friebertshäuser E; Lu Y; Meyer D; Sielaff F; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2012 Dec; 30(51):7374-80. PubMed ID: 23072892
[TBL] [Abstract][Full Text] [Related]
29. Cellular proteinases trigger the infectivity of the influenza A and Sendai viruses.
Kido H; Murakami M; Oba K; Chen Y; Towatari T
Mol Cells; 1999 Jun; 9(3):235-44. PubMed ID: 10420980
[TBL] [Abstract][Full Text] [Related]
30. DESC1 and MSPL activate influenza A viruses and emerging coronaviruses for host cell entry.
Zmora P; Blazejewska P; Moldenhauer AS; Welsch K; Nehlmeier I; Wu Q; Schneider H; Pöhlmann S; Bertram S
J Virol; 2014 Oct; 88(20):12087-97. PubMed ID: 25122802
[TBL] [Abstract][Full Text] [Related]
31. Amino acids adjacent to the haemagglutinin cleavage site are relevant for virulence of avian influenza viruses of subtype H5.
Gohrbandt S; Veits J; Hundt J; Bogs J; Breithaupt A; Teifke JP; Weber S; Mettenleiter TC; Stech J
J Gen Virol; 2011 Jan; 92(Pt 1):51-9. PubMed ID: 20881092
[TBL] [Abstract][Full Text] [Related]
32. Cleavability of hemagglutinin from an extremely virulent strain of avian influenza virus containing a unique cleavage site sequence.
Horimoto T; Ito T; Alexander DJ; Kawaoka Y
J Vet Med Sci; 1995 Oct; 57(5):927-30. PubMed ID: 8593304
[TBL] [Abstract][Full Text] [Related]
33. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
[TBL] [Abstract][Full Text] [Related]
34. The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.
Kühn N; Bergmann S; Kösterke N; Lambertz RLO; Keppner A; van den Brand JMA; Pöhlmann S; Weiß S; Hummler E; Hatesuer B; Schughart K
J Virol; 2016 May; 90(9):4298-4307. PubMed ID: 26889029
[TBL] [Abstract][Full Text] [Related]
35. Matriptase proteolytically activates influenza virus and promotes multicycle replication in the human airway epithelium.
Beaulieu A; Gravel É; Cloutier A; Marois I; Colombo É; Désilets A; Verreault C; Leduc R; Marsault É; Richter MV
J Virol; 2013 Apr; 87(8):4237-51. PubMed ID: 23365447
[TBL] [Abstract][Full Text] [Related]
36. Aprotinin and similar protease inhibitors as drugs against influenza.
Zhirnov OP; Klenk HD; Wright PF
Antiviral Res; 2011 Oct; 92(1):27-36. PubMed ID: 21802447
[TBL] [Abstract][Full Text] [Related]
37. Novel insights into proteolytic cleavage of influenza virus hemagglutinin.
Bertram S; Glowacka I; Steffen I; Kühl A; Pöhlmann S
Rev Med Virol; 2010 Sep; 20(5):298-310. PubMed ID: 20629046
[TBL] [Abstract][Full Text] [Related]
38. Modification of the cleavage activation of the influenza virus hemagglutinin by site-specific mutagenesis.
Garten W; Vey M; Ohuchi R; Ohuchi M; Klenk HD
Behring Inst Mitt; 1991 Jul; (89):12-22. PubMed ID: 1930091
[TBL] [Abstract][Full Text] [Related]
39. Location and character of the cellular enzyme that cleaves the hemagglutinin of a virulent avian influenza virus.
Walker JA; Sakaguchi T; Matsuda Y; Yoshida T; Kawaoka Y
Virology; 1992 Sep; 190(1):278-87. PubMed ID: 1529533
[TBL] [Abstract][Full Text] [Related]
40. Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses.
Baron J; Tarnow C; Mayoli-Nüssle D; Schilling E; Meyer D; Hammami M; Schwalm F; Steinmetzer T; Guan Y; Garten W; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2013 Feb; 87(3):1811-20. PubMed ID: 23192872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
